Wnt signaling/beta-catenin inhibitors (Circle/Pfizer)

N/A

Report date: 2025/01/26 17:07:37

Base Information

Drug NameWnt signaling/beta-catenin inhibitors (Circle/Pfizer)
Drug Alias NameCXCR7 chemokine modulator (Pfizer/Circle)cell permeable macrocyclic peptides (Circle/Pfizer)CXCR7
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCatenin beta 1 degradersC-X-C chemokine receptor type 7 modulatorsWingless type MMTV integration site family protein inhibitors
TargetsC-X-C chemokine receptor type 7Catenin beta 1Wingless type MMTV integration site family protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCircle Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesCircle Pharma IncPfizer Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A